Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19


© 2020 A.T.I. Arzneimittelinformation Berlin GmbH